Exact Mass: 319.0917

Exact Mass Matches: 319.0917

Found 103 metabolites which its exact mass value is equals to given mass value 319.0917, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Tetrodotoxin

(1R,5R,6R,7R,9S,11R,12R,13S,14S)-14-(hydroxymethyl)-3-imino-8,10-dioxa-2,4-diazatetracyclo[7.3.1.1(7,11).0(1,6)]tetradecane-5,9,12,13,14-pentol

C11H17N3O8 (319.1016)

A quinazoline alkaloid that is a marine toxin isolated from fish such as puffer fish. It has been shown to exhibit potential neutotoxicity due to its ability to block voltage-gated sodium channels. D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D000777 - Anesthetics D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002317 - Cardiovascular Agents > D026941 - Sodium Channel Blockers D009676 - Noxae > D011042 - Poisons > D008387 - Marine Toxins D049990 - Membrane Transport Modulators C93038 - Cation Channel Blocker Tetrodotoxin. CAS Common Chemistry. CAS, a division of the American Chemical Society, n.d. https://commonchemistry.cas.org/detail?cas_rn=4368-28-9 (retrieved 2024-09-06) (CAS RN: 4368-28-9). Licensed under the Attribution-Noncommercial 4.0 International License (CC BY-NC 4.0).

RO19-4603

Ro 19-4603

C15H17N3O3S (319.0991)

Benzamil

3,5-diamino-N-(N-benzylcarbamimidoyl)-6-chloropyrazine-2-carboxamide

C13H14ClN7O (319.0948)

ci no 52015

Methylthioninium Chloride

C16H18ClN3S (319.091)

V - Various > V03 - All other therapeutic products > V03A - All other therapeutic products > V03AB - Antidotes V - Various > V04 - Diagnostic agents > V04C - Other diagnostic agents > V04CG - Tests for gastric secretion COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials D004791 - Enzyme Inhibitors Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS

Ibandronate

{1-hydroxy-3-[methyl(pentyl)amino]-1-phosphonopropyl}phosphonic acid

C9H23NO7P2 (319.095)

Ibandronate is a nitrogen-containing bisphosphonate in the same class as alendronate and risedronate. Ibandronate inhibits osteoclast-mediated bone resorption. All of the bisphosphonates prevent the breakdown of bone by bone cells called osteoclasts. In persons who are at high risk for osteoporosis, bisphosphonates not only result in increased amounts of bone and bone strength, they also reduce the risk of hip fractures and other bone fractures. M - Musculo-skeletal system > M05 - Drugs for treatment of bone diseases > M05B - Drugs affecting bone structure and mineralization > M05BA - Bisphosphonates C78281 - Agent Affecting Musculoskeletal System > C67439 - Bone Resorption Inhibitor D050071 - Bone Density Conservation Agents > D004164 - Diphosphonates

N-(p-Toluenesulfonyl)-L-phenylalanine

2-(4-methylbenzenesulfonamido)-3-phenylpropanoic acid

C16H17NO4S (319.0878)

5,9:7,10a-Dimethano-10aH-[1,3]dioxocino[6,5-d]pyrimidine-4,7,10,11,12-pentol, octahydro-12-(hydroxymethyl)-2-imino-,(4R,4aR,5R,7S,9S,10S,10aR,11S,12S)-

C11H17N3O8 (319.1016)

D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D000777 - Anesthetics D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002317 - Cardiovascular Agents > D026941 - Sodium Channel Blockers D009676 - Noxae > D011042 - Poisons > D008387 - Marine Toxins D049990 - Membrane Transport Modulators

Decarine

[1,3]Benzodioxolo[5,6-c]phenanthridin-2-ol, 1-methoxy-

C19H13NO4 (319.0845)

A natural product found particularly in Zanthoxylum caudatum and Zanthoxylum viride.

brevianamide N

C18H13N3O3 (319.0957)

(7R,8S)-7,8-dihydroxyrutaecarpine

C18H13N3O3 (319.0957)

SCHEMBL13886471

C11H17N3O8 (319.1016)

Norisoterihanin

C19H13NO4 (319.0845)

Usutalic imide

C19H13NO4 (319.0845)

1,2-Dihydroxyrutaecarpine

C18H13N3O3 (319.0957)

2-(3,4-dihydro-2-methoxy-4-oxoquinazolinyl)-1H-indole-3-carboxaldehyde|orirenierine B

C18H13N3O3 (319.0957)

CHEMBL3597759

C19H13NO4 (319.0845)

Ala Asp Asp

C11H17N3O8 (319.1016)

Gly Asp Glu

C11H17N3O8 (319.1016)

Gly Glu Asp

C11H17N3O8 (319.1016)

Asp Ala Asp

C11H17N3O8 (319.1016)

Asp Asp Ala

C11H17N3O8 (319.1016)

MMV202458

C17H18NO3Cl (319.0975)

1,N2-6-Oxo-malondialdehyde-deoxyguanosine

C13H13N5O5 (319.0917)

Asp Gly Glu

C11H17N3O8 (319.1016)

Glu Gly Asp

C11H17N3O8 (319.1016)

Glu Asp Gly

C11H17N3O8 (319.1016)

Asp Glu Gly

C11H17N3O8 (319.1016)

Ibandronate

Ibandronate sodium;Ibandronate sodium monohydrate;Ibandronic Acid;R484

C9H23NO7P2 (319.095)

M - Musculo-skeletal system > M05 - Drugs for treatment of bone diseases > M05B - Drugs affecting bone structure and mineralization > M05BA - Bisphosphonates C78281 - Agent Affecting Musculoskeletal System > C67439 - Bone Resorption Inhibitor D050071 - Bone Density Conservation Agents > D004164 - Diphosphonates